187 related articles for article (PubMed ID: 18297447)
1. Pharmacokinetic modeling and dosage adaptation of biapenem in Japanese patients during continuous venovenous hemodiafiltration.
Ikawa K; Morikawa N; Ikeda K; Suyama H
J Infect Chemother; 2008 Feb; 14(1):35-9. PubMed ID: 18297447
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of once-daily arbekacin during continuous venovenous hemodiafiltration in critically ill patients.
Ikawa K; Morikawa N; Suyama H; Ikeda K; Yamanoue T
J Infect Chemother; 2009 Dec; 15(6):420-3. PubMed ID: 20012736
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients.
Robatel C; Decosterd LA; Biollaz J; Eckert P; Schaller MD; Buclin T
J Clin Pharmacol; 2003 Dec; 43(12):1329-40. PubMed ID: 14615469
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients.
Guenter SG; Iven H; Boos C; Bruch HP; Muhl E
Pharmacotherapy; 2002 Feb; 22(2):175-83. PubMed ID: 11837556
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of biapenem in critically ill patients under continuous venovenous hemodiafiltration.
Suyama H; Ikawa K; Morikawa N; Ikeda K; Fujiue Y; Morikawa S; Kaneko K; Kuwabara M; Yamanoue T
Jpn J Antibiot; 2008 Oct; 61(5):303-13. PubMed ID: 19260350
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
Giles LJ; Jennings AC; Thomson AH; Creed G; Beale RJ; McLuckie A
Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806
[TBL] [Abstract][Full Text] [Related]
7. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
Mariat C; Venet C; Jehl F; Mwewa S; Lazarevic V; Diconne E; Fonsale N; Carricajo A; Guyomarc'h S; Vermesch R; Aubert G; Bidault R; Bertrand JC; Zeni F
Crit Care; 2006 Feb; 10(1):R26. PubMed ID: 16507147
[TBL] [Abstract][Full Text] [Related]
8. A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration.
Sime FB; Lassig-Smith M; Starr T; Stuart J; Pandey S; Parker SL; Wallis SC; Lipman J; Roberts JA
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658965
[TBL] [Abstract][Full Text] [Related]
9. Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
Roberts JA; Udy AA; Bulitta JB; Stuart J; Jarrett P; Starr T; Lassig-Smith M; Roberts NA; Dunlop R; Hayashi Y; Wallis SC; Lipman J
J Antimicrob Chemother; 2014 Sep; 69(9):2508-16. PubMed ID: 24879665
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltration.
Roger C; Muller L; Wallis SC; Louart B; Saissi G; Lipman J; Lefrant JY; Roberts JA
J Antimicrob Chemother; 2016 Feb; 71(2):464-70. PubMed ID: 26538503
[TBL] [Abstract][Full Text] [Related]
11. Are interstitial fluid concentrations of meropenem equivalent to plasma concentrations in critically ill patients receiving continuous renal replacement therapy?
Varghese JM; Jarrett P; Wallis SC; Boots RJ; Kirkpatrick CM; Lipman J; Roberts JA
J Antimicrob Chemother; 2015 Feb; 70(2):528-33. PubMed ID: 25336163
[TBL] [Abstract][Full Text] [Related]
12. Evaluating biapenem dosage regimens in intensive care unit patients with Pseudomonas aeruginosa infections: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.
Hang Y; Chen Y; Xue L; Sun S; Liu L; Gao J; Xie C; Zhang X; Zhu J; Jin J; Miao L
Int J Antimicrob Agents; 2018 Mar; 51(3):484-487. PubMed ID: 28709989
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration.
Ververs TF; van Dijk A; Vinks SA; Blankestijn PJ; Savelkoul JF; Meulenbelt J; Boereboom FT
Crit Care Med; 2000 Oct; 28(10):3412-6. PubMed ID: 11057794
[TBL] [Abstract][Full Text] [Related]
14. Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients.
Roger C; Cotta MO; Muller L; Wallis SC; Lipman J; Lefrant JY; Roberts JA
Int J Antimicrob Agents; 2017 Aug; 50(2):227-231. PubMed ID: 28689876
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration.
Wallis SC; Mullany DV; Lipman J; Rickard CM; Daley PJ
Intensive Care Med; 2001 Apr; 27(4):665-72. PubMed ID: 11398692
[TBL] [Abstract][Full Text] [Related]
16. Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.
Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Lefrant JY; Roberts JA
Antimicrob Agents Chemother; 2016 Aug; 60(8):4901-9. PubMed ID: 27270279
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
DelDot ME; Lipman J; Tett SE
Br J Clin Pharmacol; 2004 Sep; 58(3):259-68. PubMed ID: 15327585
[TBL] [Abstract][Full Text] [Related]
18. Linezolid clearance during continuous venovenous hemodiafiltration: a case report.
Kraft MD; Pasko DA; DePestel DD; Ellis JJ; Peloquin CA; Mueller BA
Pharmacotherapy; 2003 Aug; 23(8):1071-5. PubMed ID: 12921253
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients.
Malone RS; Fish DN; Abraham E; Teitelbaum I
Antimicrob Agents Chemother; 2001 Nov; 45(11):3148-55. PubMed ID: 11600370
[TBL] [Abstract][Full Text] [Related]
20. Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenem.
Cirillo I; Vaccaro N; Balis D; Redman R; Matzke GR
Antimicrob Agents Chemother; 2011 Mar; 55(3):1187-93. PubMed ID: 21199922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
